cyclen has been researched along with Hypoxia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhise, A; Bobba, KN; Huynh, PT; Kim, JY; Sarkar, S; Yoo, J | 1 |
Brothers, PJ; Chang, JY; Denny, WA; Lu, GL; Stevenson, RJ; Tercel, M; Ware, DC; Wilson, WR | 1 |
2 other study(ies) available for cyclen and Hypoxia
Article | Year |
---|---|
Development of dansyl based copper(ii) complex to detect hydrogen sulfide in hypoxia.
Topics: Animals; Cell Survival; Coordination Complexes; Copper; Cyclams; Dansyl Compounds; Dose-Response Relationship, Drug; Fluorescent Dyes; HeLa Cells; Heterocyclic Compounds; Humans; Hydrogen Sulfide; Hypoxia; Mice; Molecular Structure; Optical Imaging; Structure-Activity Relationship; Tumor Cells, Cultured | 2019 |
N-alkylated cyclen cobalt(III) complexes of 1-(chloromethyl)-3-(5,6,7-trimethoxyindol-2-ylcarbonyl)-2,3-dihydro-1H-pyrrolo[3,2-f]quinolin-5-ol DNA alkylating agent as hypoxia-activated prodrugs.
Topics: Alkylation; Antineoplastic Agents, Alkylating; Azo Compounds; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Cobalt; Cyclams; DNA; Drug Screening Assays, Antitumor; Drug Stability; Female; Heterocyclic Compounds; Humans; Hypoxia; Indoles; Prodrugs; Solubility; Trace Elements | 2011 |